One consortium to unite a growing international movement.

The era of genomic sequencing in medicine has arrived.

Scientists have long predicted that newborn sequencing would one day become a routine health check at birth, offering parents early guidance on care that is tailored to their child.

Researchers from around the globe have been independently studying the implementation of newborn sequencing, slowly moving us closer to realizing that goal.

We convened ICoNS to accelerate that process by bringing these world-class experts together to share knowledge, research plans, and results from the original eight studies in newborn sequencing.

This newly founded consortium introduced themselves and their mission to the world at the inaugural International Conference on Newborn Sequencing, held in Boston in 2022.

Since then, we’ve assembled the ICoNS Steering Committee, a governing body of project leaders who founded the consortium, to drive this growing movement steadily toward success.

Now, with all contributing partners under one umbrella, we can concentrate all of the world’s research on newborn genomics into one unified effort to improve public health for all.

The ICoNS Steering Committee

The path forward begins with us.

ICoNS is growing daily, with more and more partners from around the world joining the movement and contributing their research to propel us toward the dream of preventive genomics as routine medicine.

Approaching 30 individual consortium members and the multitude of researchers, healthcare providers, vendors, and laboratories they bring with them, ICoNS is the premier collection of experts in the field.

ICoNS welcomes thought-leaders across all fields that are actively participating in newborn sequencing implementation projects, or are imminently preparing to do so.

The Consortium Members

click to expand

  • Don Bailey, PhD, MeD

    EarlyCheck

    RTI International

  • Emma Baple, MBBS, MRCPH, PhD

    Royal Devon University

    NHS Foundation Trust

  • David Bick, MD

    Genomics England

  • Amy Brower, PhD

    NBSTRN

  • Dr. David Brown

    Qatar Precision Medicine Institute

  • Wendy K. Chung, MD, PhD

    GUARDIAN Study

    Boston Children’s Hospital

  • Lilian Downie MBBS, FRACP, PhD

    Victorian Clinical Genetics Services

    BabyScreen+

  • Nicolas Encina, MS, MBA

    Ariadne Labs

    Harvard University

  • Laurence Faivre, MD, PhD

    Centre de Génétique et Centre de Référence Anomalies du Développement et Syndromes Malformatifs

  • Alessandra Ferlini, MD, PhD

    Screen4Care

    University of Ferrara

  • Nicolas Garnier, PhD

    Pfizer

  • Robert C. Green, MD, MPH

    Genomes2People

    Brigham and Women’s Hospital

    Harvard Medical School

  • Scott Grosse, PhD

    CDC, DDNID, NCBDDD, OD

  • Lidewij Henneman, PhD

    Amsterdam University Medical Centers

  • Mark David Kilby, DSc, MBBS, MD, FRCPI, FRCOG

    Illumina

  • Stephen Kingsmore MD, DSC

    BeginNGS, Rady Children's Institute for Genomic Medicine

  • Sebastian Lunke, PhD

    BabyScreen+

  • Gert Matthijs, PhD

    UZ Leuven

  • Holly Peay, PhD, MS, CGC

    EarlyCheck

    RTI International

  • Richard Scott, MD, PhD

    Genomics England

  • Zornitza Stark, MD

    BabyScreen+

  • Kris Van Den Bogaert, MS, PhD

    KU Leuven

  • Els Voorhoeve, MS

    Centre for Health Protection, National Institute for Public Health and the Environment

  • Melissa Wasserstein, MD

    ScreenPlus Chief, Division of Pediatric Genetic Medicine Children's Hospital at Montefiore

  • Bethany Zettler, MS, CGC

    BabySeq

    Genomes2People

  • Karin Kassahn, PhD

    NewbornsInSA

    SA Pathology and The University of Adelaide

  • Laurent Servais, MD, PhD

    BabyDetect Project

    University of Oxford

    Hôpital de La Citadelle

  • BOEMER François, PharmD, EuSpLM, PhD

    BabyDetect Project

    Newborn Screening Centre

    Human Genetics

    CHU Liege, BELGIUM

  • Jovanka King, PhD FRACP FRCPA BMBS (Hons) BPod

    NewbornsInSA

    Women’s & Children’s Health Network, SA Pathology & The University of Adelaide

  • Carol W.K. Siu, MBBS, PhD, FRCPA, FRCPath

    NewbornsInSA

    SA Pathology and The University of Adelaide

  • Petros Tsipouras, MD

    FirstSteps

  • Gulcin Gumus, PhD

    Research & Policy Senior Manager EURORDIS - Rare Diseases Europe

Do you have a project in the field? You’re invited to join the movement.